新冠肺炎致死真相:肾衰、心衰发生率远高于SARS,或与ACE2受体分布有关?

2020-02-15 Walter 转化医学网

第三军医大学谌小维、周艺、鄢俊安及中国科学院苏州生物医学工程技术研究所贾宏博团队在医学预印本网站Medrxiv上发表结果,发现新冠肺炎的新临床特征:病例中肾功能衰竭的发生率远高于SARS,并强烈建议及时检测重症患者的肾功能,可能是大大降低死亡比例的关键。




第三军医大学谌小维、周艺、鄢俊安及中国科学院苏州生物医学工程技术研究所贾宏博团队在医学预印本网站Medrxiv上发表结果,发现新冠肺炎的新临床特征:病例中肾功能衰竭的发生率远高于SARS,并强烈建议及时检测重症患者的肾功能,可能是大大降低死亡比例的关键。

2003年SARS的病例分析中,临床上出现肾功能不全的患者数量极少,但死亡率极高(91.7%,33/36)。由于SARS-CoV与新冠病毒的同源性,研究者假设肾功能可能也与新型肺炎病例的死亡有关。因此,研究者分析了来自武汉、黄石河重庆多家医院的59名病例数据,其中重症28例,调查他们在2020年1月21日到2月7日之间的肾功能状况。结果如下:

1. 63%新冠肺炎患者出现蛋白尿

51例新冠肺炎患者中,32例出现蛋白尿。通过蛋白尿半衰期检测发现,47%为轻度蛋白尿,10%为中度,6%为重度。64%蛋白尿患者在入院第一天就出现了该症状,提示肾小球滤过作用的损坏在新冠肺炎早期就已开始发展。


新冠肺炎患者出现蛋白尿

2. 27%新冠肺炎患者尿素氮水平升高

59例新冠肺炎患者中,16例发生尿素氮升高,其中43%在住院后2-10天尿素氮持续升高,2/3死亡病例去世前尿素氮含量达到顶峰,说明肾小管的损害随新冠肺炎进程而加重。


新冠肺炎患者尿素氮水平升高

3. 19%新冠肺炎患者血浆肌酐水平升高

59例新冠肺炎患者中,11例产生血浆肌酐含量升高,峰值浓度最高可达正常值的5.97倍,3例死亡患者去世前血浆肌酐含量达到峰值。


新冠肺炎患者血浆肌酐升高

4. 100%患者肾脏CT影像学检测异常

在接受检测CT检测的27例患者中,均发现了肾脏的影像学异常,包括肾实质厚度显著减小,提示肾脏炎症和水肿的产生。


新型肺炎患者肾脏影像学异常

研究者认为,这可能与SARS-CoV-2点受体蛋白ACE2在肾脏的高表达有关。此前研究用RNA测序手段统计人体内ACE2蛋白的分布情况,发现肾脏中的ACE2表达量较呼吸道高出近100倍。2月13日医学预印本上发表的另一篇论文也得出了类似的结论,发现ACE2在肾脏肾小管和睾丸组织高表达。


ACE2在人体组织的表达情况

然而,既然SARS-CoV与新冠病毒均结合于ACE2蛋白,进而感染人体,那便无法解释为何新冠肺炎肾功能损害的发生率与SARS的差异如此巨大。

另外,在2月13日的湖北疫情防控新闻发布会上,中央指导组介绍在此前的救治经验中发现,新冠肺炎患者心脏受病毒的攻击较2003年非典更为严重,患者心肌的肌酐蛋白异常增高。新冠肺炎在重症病例中所表现出的新临床特征,暗示新冠肺炎的在与非典不同的角度表现出它的迅猛之势,也向临床一线提出新的挑战。

总之,多方面证据表明,肾功能损伤在新冠肺炎患者中很常见,最终可能引起多器官衰竭,进一步加重感染并导致死亡。因此,应谨慎监测新冠肺炎患者的肾脏、心脏功能,应及时采取连续性肾脏替代疗法(CRRT)等干预手段保护肾脏功能,是减少重症患者死亡的关键;而肾脏和男性生殖功能也应纳入出院患者后续健康的考量范围之内。

原始出处:

Anti-2019-nCoV Volunteers, et al. Caution on Kidney Dysfunctions of 2019-nCoV Patients. MedRxiv. 13 Feb, 2020.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
    2020-11-29 shanyongle
  2. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
    2020-03-29 Tionecho

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
    2020-02-16 小刀医生
  5. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
    2020-02-15 QQ047a06da

    我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
    2020-02-15 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
    2020-02-15 33141725_96279859

    希望早日攻克新冠肺炎

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1655991, encodeId=3b8e1655991a0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Sun Nov 29 19:19:00 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826573, encodeId=f8d118265e354, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Sep 03 00:19:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381109, encodeId=333d381109d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ac11607114, createdName=Tionecho, createdTime=Sun Mar 29 12:36:49 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321147, encodeId=f24e132114ede, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382994, encodeId=a26b138299425, content=<a href='/topic/show?id=b4c118301c' target=_blank style='color:#2F92EE;'>#ACE2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1830, encryptionId=b4c118301c, topicName=ACE2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 16 23:19:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379276, encodeId=4f0e3e9276b9, content=我想知道某个脏器功能障碍时炎性因子水平。同时是否是动态观察水平?, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=444b1718665, createdName=QQ047a06da, createdTime=Sat Feb 15 16:59:51 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027174, encodeId=568d102e174b4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 15 11:19:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379264, encodeId=77c73e926494, content=希望早日攻克新冠肺炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/e7fddaace9d884d73cee8d16e20a9a94.jpg, createdBy=9ef65279836, createdName=33141725_96279859, createdTime=Sat Feb 15 10:03:25 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379260, encodeId=d8513e9260f3, content=那后期的并发症是不是更多?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96195231140, createdName=zilinger108, createdTime=Sat Feb 15 09:43:05 CST 2020, time=2020-02-15, status=1, ipAttribution=)]
    2020-02-15 zilinger108

    那后期的并发症是不是更多?

    0

相关资讯

Lancet:反对滥用激素,但重症可谨慎应用!中国一线医师回应Lancet述评

2月7日,Lancet杂志在线发表述评文章,认为目前的临床证据不支持用激素来治疗新型冠状病毒肺炎(新冠肺炎)。

托珠单抗登记新冠肺炎临床试验

2月13日,据中国临床试验注册中心显示,「托珠单抗」登记了一项 在新型冠状病毒肺炎(COVID-19)中的有效性及安全性的多中心、随机对照临床研究(注册号:ChiCTR2000029765 )。该项研究的目的是评估托珠单抗治疗普通型NCP(含重症高危因素)及重型NCP患者的有效性和安全性 。托珠单抗是一种白介素-6受体阻断剂,最早在2010年1月8日获美国FDA批准用于治疗患中度至重度活

MedRvix:年龄≥50岁且淋巴细胞明显降低的新冠肺炎,应尽快收入重症监护室

2月12日,首都医科大学附属北京地坛医院研究中性粒细胞/淋巴细胞比值人员在医学生物类论文预印本平台medRvix发表的一项研究提示,中性粒细胞/淋巴细胞比值(NLR)有助于早期发现重症新型冠状病毒肺炎(新冠肺炎)患者。

“观肺”不可忘“护心”,心衰患者该如何应对“新冠”疫情?

新型冠状病毒肺炎(以下简称“新冠肺炎”)自2019年12月暴发,至今疫情蔓延至全国乃至全球多个国家及地区,给人们生活带来巨大影响。人群对新型冠状病毒普遍易感。但从各地报告来看,老年人感染后病情较重,特别是患有心血管系统疾病、呼吸系统疾病等慢性基础疾病的患者。

Lancet:糖皮质激素在新冠肺炎中的应用,听听中国一线医生的观点

前几日,Lancet刊登了Clark Russell等撰写的一篇评论文章[1],文章认为,在非临床试验的情况下,激素不应该用于治疗2019-nCoV导致的肺损伤或休克。针对此文,柳叶刀近日刊登了中日医院曹彬教授作为通讯作者的一篇文章“On the use of corticosteroids for 2019-nCoV pneumonia”,从中国一线临床医生的角度,提出了不同的看法。全文链接

疫情将在2月中下旬达到峰值,李兰娟团队救治模式初显成效

目前,对抗新冠肺炎的“战役”还没有结束,但是已经传来了一系列好消息。